Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Filings indexed 293 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 92% confidence The document is a Form 52-109FV2 Venture Issuer Basic Certificate, a CEO attestation certifying that the interim financial report and MD&A have been reviewed and present fairly. It contains no actual financial data or report content but is an officer certification letter referencing interim filings. Under the Certification Rule, such attestations are classified as Regulatory Filings (RNS), not as the interim report itself.
2026-05-21 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press release from Medicure Inc. titled “MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2026 AND SCHEDULES MAY 25, 2026 CONFERENCE CALL,” summarizing key quarterly financial highlights (net revenue, EBITDA, net loss per share), operational segment performance, cash position, and providing conference call details. It represents the initial announcement of quarterly results to the market rather than a comprehensive interim report with full financial statements or an Excel supplement. Therefore, it is classified as an Earnings Release (ER). Q1 2026
2026-05-21 English
Form of proxy - English.pdf
Regulatory Filings
2026-05-07 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 81% confidence The document is a FORM 52-109FV1 ‘Venture Issuer Basic Certificate’ – an officer’s certification under Canadian NI 52-109 confirming review of AIF, financial statements and MD&A. It is not the annual report itself, nor an announcement of a report, but a required regulatory filing (certification form). It does not fit any other specific category, so it is classified as a general Regulatory Filing (RNS).
2026-04-24 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a certification under Form 52-109FV1 required by Canadian securities rules, attesting to the review and fair presentation of the annual filings (AIF, financial statements, MD&A) for the year ended December 31, 2025. It is not itself the full annual report or MD&A, but rather a regulatory certification filing. There are no indications it is an earnings release, management discussion, or other specific category. Thus it falls under the general regulatory announcement category.
2026-04-24 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a Notice of Annual General and Special Meeting of Shareholders, including agenda items, record date and detailed proxy voting instructions. It is part of the proxy solicitation package (Notice, Information Circular, Proxy Form) sent to shareholders to obtain their votes at the meeting. This matches the Proxy Solicitation & Information Statement category (PSI).
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.